AR and metabolic dysfunction-associated steatotic liver disease: Resultantly, we found almost no DEGs involved in de novo fatty acid synthesis/cell cycle were with potential AR binding sites within their promoter regions, suggesting active androgens derived from adrenal androgen precursors exert anti-NAFLD effect through indirect pathways.